Alpha-1 Antitrypsin Deficiency (Alpha-1) is a genetic (inherited) condition – it is passed from parents to their children through their genes. Alpha-1 may result in serious lung disease in adults and/or liver disease at any age.
The Alpha-1 Foundation encourages testing for Alpha-1 among those at high risk for this genetic disorder. Anyone can ask their doctor to test them for Alpha-1 or they may choose to be tested confidentially.
Coronavirus (COVID-19) Update: FDA Takes Additional Actions on the Use of a Booster Dose for COVID-19 Vaccines
For Immediate Release: October 20, 2021 Today, the U.S. Food and Drug Administration took action to expand the use of...
CDC Expands Eligibility for COVID-19 Booster Shots
Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’...
Alpha-1 Foundation stands with ATS regarding FDA Authorization of E-cigarette Product
"The Alpha-1 Foundation strongly agrees with the American Thoracic Society (ATS) position objecting to the FDA's...
Accreditations
